中华整形外科杂志
中華整形外科雜誌
중화정형외과잡지
CHINESE JOURNAL OF PLASTIC SURGERY
2010年
3期
203-207
,共5页
张俊成%谢有富%刘思隽%戴丽冰%李建平
張俊成%謝有富%劉思雋%戴麗冰%李建平
장준성%사유부%류사준%대려빙%리건평
瘢痕,肥大性%受体,褪黑激素,MT1%受体,褪黑激素,MT2
瘢痕,肥大性%受體,褪黑激素,MT1%受體,褪黑激素,MT2
반흔,비대성%수체,퇴흑격소,MT1%수체,퇴흑격소,MT2
Cicatrix,hypertrophic%Receptor,melatonin,MT1%Receptor,melatonin,MT2
目的 检测人增生性瘢痕组织和正常皮肤中褪黑素受体含量的差异,探讨其意义.方法 人增生性瘢痕组织和正常皮肤各10例,免疫组化检测组织中褪黑素受体GPR50的表达,荧光定量PCR(SYBR Green)检测组织中褪黑素受体MT1、MT2 mRNA含量,并将PCR阳性产物基因测序.结果 免疫组化显示褪黑素受体GPR50表达于细胞膜和细胞质,正常皮肤表皮基底层细胞、毛囊和汗腺均有褪黑素受体阳性表达,增生性瘢痕组织表皮、残留的毛囊和汗腺内也存在褪黑素受体表达;同时发现增生性瘢痕真皮成纤维细胞有广泛褪黑素受体阳性表达,而正常皮肤组织中则少见表达.荧光定量PCR显示增生性瘢痕组织中MT1、MT2 mRNA含量分别为(1.16584 4±0.21829)和(0.99550 ±0.14624)拷贝数/μl cDNA,正常皮肤中为(0.99081±0.26485)和(0.77083±0.15927)拷贝数/μl cDNA,增生性瘢痕组织中MT1、MT2 mRNA含量均高于正常皮肤(P<O.05),同时MT1 mRNA含量在两种组织中均高于MT2 mRNA(P<0.05);基因测序显示扩增产物与GeneBank中人MT1、MT2受体基因序列相吻合.结论 褪黑素受体在增生性瘢痕组织和正常皮肤中均有表达,而且在增生性瘢痕组织中高于正常皮肤,褪黑素受体在增生性瘢痕形成过程中可能发挥着重要作用.
目的 檢測人增生性瘢痕組織和正常皮膚中褪黑素受體含量的差異,探討其意義.方法 人增生性瘢痕組織和正常皮膚各10例,免疫組化檢測組織中褪黑素受體GPR50的錶達,熒光定量PCR(SYBR Green)檢測組織中褪黑素受體MT1、MT2 mRNA含量,併將PCR暘性產物基因測序.結果 免疫組化顯示褪黑素受體GPR50錶達于細胞膜和細胞質,正常皮膚錶皮基底層細胞、毛囊和汗腺均有褪黑素受體暘性錶達,增生性瘢痕組織錶皮、殘留的毛囊和汗腺內也存在褪黑素受體錶達;同時髮現增生性瘢痕真皮成纖維細胞有廣汎褪黑素受體暘性錶達,而正常皮膚組織中則少見錶達.熒光定量PCR顯示增生性瘢痕組織中MT1、MT2 mRNA含量分彆為(1.16584 4±0.21829)和(0.99550 ±0.14624)拷貝數/μl cDNA,正常皮膚中為(0.99081±0.26485)和(0.77083±0.15927)拷貝數/μl cDNA,增生性瘢痕組織中MT1、MT2 mRNA含量均高于正常皮膚(P<O.05),同時MT1 mRNA含量在兩種組織中均高于MT2 mRNA(P<0.05);基因測序顯示擴增產物與GeneBank中人MT1、MT2受體基因序列相吻閤.結論 褪黑素受體在增生性瘢痕組織和正常皮膚中均有錶達,而且在增生性瘢痕組織中高于正常皮膚,褪黑素受體在增生性瘢痕形成過程中可能髮揮著重要作用.
목적 검측인증생성반흔조직화정상피부중퇴흑소수체함량적차이,탐토기의의.방법 인증생성반흔조직화정상피부각10례,면역조화검측조직중퇴흑소수체GPR50적표체,형광정량PCR(SYBR Green)검측조직중퇴흑소수체MT1、MT2 mRNA함량,병장PCR양성산물기인측서.결과 면역조화현시퇴흑소수체GPR50표체우세포막화세포질,정상피부표피기저층세포、모낭화한선균유퇴흑소수체양성표체,증생성반흔조직표피、잔류적모낭화한선내야존재퇴흑소수체표체;동시발현증생성반흔진피성섬유세포유엄범퇴흑소수체양성표체,이정상피부조직중칙소견표체.형광정량PCR현시증생성반흔조직중MT1、MT2 mRNA함량분별위(1.16584 4±0.21829)화(0.99550 ±0.14624)고패수/μl cDNA,정상피부중위(0.99081±0.26485)화(0.77083±0.15927)고패수/μl cDNA,증생성반흔조직중MT1、MT2 mRNA함량균고우정상피부(P<O.05),동시MT1 mRNA함량재량충조직중균고우MT2 mRNA(P<0.05);기인측서현시확증산물여GeneBank중인MT1、MT2수체기인서렬상문합.결론 퇴흑소수체재증생성반흔조직화정상피부중균유표체,이차재증생성반흔조직중고우정상피부,퇴흑소수체재증생성반흔형성과정중가능발휘착중요작용.
Objective To investigate the expression and its significance of melatonin receptor in human hypertrophic scarring. Methods The expression of melatonin receptor GPR50 was detected with immunohistochemistiy and the melatonin receptors( MT1 、MT2)mRNA were assessed with RT-PCR method in 10 cases of human hypertrophic scar and normal skin. The positive production was sequenced with auto sequencing instrument. Results Positive signals of melatonin receptor could be found in the cell membrane and cytoplasm. The melatonin receptor GPR50 was located in the epithelial basal cells, sweat gland cells and hair follicle in both hypertrophic scar and normal skin. The melatonin receptor GPR50 was extensively expressed in fibroblasts of hypertrophic scar, but not in fibroblasts in normal skin. RT-PCR showed that the expression of melatonin receptor( MT1, MT2 ) mRNA in hypertrophic scar was significantly higher than that in normal skin( P <0. 05). In normal skin and hypertrophic scar group, the expression of MT1 mRNA was higher than MT2 mRNA ( P < 0. 05 ) . In normal skin and hypertrophic scar group, the expression of MT1 mRNA was 0.99081 ±0.26485 and 1.16584 ±0.21829 copy number/μl cDNA, respectively;the expression of MT2 mRNA was 0. 77083 ±0. 15927and 0. 99550 ±0. 14624 copy number/ μl cDNA, respectively. Sequencing results indicated that the positive product coincided with cDNA of human melatonin receptor in GeneBank. Conclusions Positive expression of melatonin receptor can be found in human hypertrophic scar and normal skin, but it is higher in scar. The over expression of melatonin receptor in hypertrophic scar may be related to the development of hypertrophic scar.